Top compounds associated with response to MYBL1


Feature Type Standardized
Nominal ANOVA
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.12 0.03
mRNA L-685458 CCLE pan-cancer AAC -0.1 0.03
mRNA Parthenolide GDSC1000 pan-cancer AAC 0.12 0.03
mRNA Axitinib GDSC1000 pan-cancer AAC -0.083 0.03
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.075 0.03
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.11 0.03
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.098 0.03
mRNA TKI258 CCLE pan-cancer AAC -0.1 0.03
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.03
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
Download CSV